RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM)

CUSIP: 76243J105

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+1,953,240
Put/Call ratio
73%
SEC-reported price per share
$107.04
Number of holders
279
Value change
+$220,704,819
Number of buys
155
Open additional details 1 more signal available
Number of sells
128
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
69,875,824

Security key

76243J105

Report period

Q4 2025

Institutions

279

Top holders

10

Ownership snapshot

Top reported holders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
5/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 9.9% 10 rows are not safely comparable across share classes. 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 9.9%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 9.9%
BAKER BROS. ADVISORS LP 8.9%
BlackRock, Inc. 6.9%
PRIMECAP MANAGEMENT CO/CA/ 5.2%
GOLDMAN SACHS GROUP INC 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
9.9%
Reported 13D/G · 31 Dec 2025
$662,816,935
6,666,837 shares
+$109,906,623 31 Dec 2025
BAKER BROS. ADVISORS LP
13F 13D/G
Company
8.9%
Reported 13D/G · 31 Mar 2025
$565,996,738
5,604,483 shares
— 30 Sep 2025
BlackRock, Inc.
13F 13D/G
Company
6.9%
Reported 13D/G · 31 Mar 2025
$636,460,694
6,302,215 shares
— 30 Sep 2025
PRIMECAP MANAGEMENT CO/CA/
13F 13D/G
Company
5.2%
Reported 13D/G · 31 Dec 2025
$430,506,130
4,262,859 shares
— 30 Sep 2025
GOLDMAN SACHS GROUP INC
13F 13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
3%
Reported 13D/G · 31 Dec 2024
$191,241,026
1,893,663 shares
— 30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$504,589,163
4,996,427 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
279
Shares
72,869,773
Rows available
279
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
263
Q4 2025 holders
279
Holder diff
16
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .